LONG ISLAND, N.Y., March 18, 2026 /PRNewswire/ -- Ottobock, a global leader in prosthetics, orthotics, and human mobility solutions, is proud to kick off its first Full Circle Movement (FCM) event of 2026 on Long Island, continuing its commitment to inclusive, community-driven experiences for people with limb loss or limb difference. Continue Reading Full Circle Movement volunteers support a participant with mobility drills. The Long Island Full Circle Movement will take place across two days in

Vantage Health Technologies' SocialHealth360® platform demonstrates measurable improvements in cancer care outcomes by addressing social determinants of health VIRGINIA BEACH, Va., March 18, 2026 /PRNewswire/ -- Decisions and ProcessMaker, recently merged providers of leading global business process automation and AI orchestration platforms, today announced how Decisions customer Vantage Health Technologies, part of the BroadReach Group, is transforming oncology care through SocialHealth360®, a

Amigo and Nortal sign partnership agreement to offer healthcare organizations an end-to-end solution from AI strategy to clinical outcomes Nortal to lead healthcare transformation strategy with Amigo delivering clinical AI technology and expertise Use cases include clinical triage, 24/7 virtual care, and proactive patient outreach NEW YORK, March 18, 2026 /PRNewswire/ -- Amigo, the platform for building patient-facing clinical AI agents, today announced a strategic partnership with Nortal. Th

WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory cloud EHR, today announced that Johnson Health Center (JHC) is leveraging Sunoh.ai to streamline clinical documentation and reduce administrative burden across its 78-provider organization. The AI-powered medical scribe is helping JHC clinicians save significant time per patient visit, enabling them to spend more time engaging with patients while reducing documentation fatigue. As a Federally Qualified Health Center (FQ

Results Show Continued Safety, Tolerability, and Sustained Clinical Benefit Including Improvements in Function, Physician- and Patient-Reported Outcomes, and Quality-of-Life This Personalized Autologous Cell Therapy Aims to Replace and Restore the Damaged Neural Circuitry in Parkinson's Patients that Underpins Everyday Movement and Function, Without the Need for Immune Suppression SAN DIEGO, March 18, 2026 /PRNewswire/ -- Aspen Neuroscience, a clinical-stage regenerative medicine company develop

近日，晶泰科技孵化企业莱芒生物宣布，其研发的 META 10-19 注射液（代谢增强型 CD19 CAR-T）的新药临床试验申请（IND）已获得美国食品药品监督管理局（FDA）批准，计划最早于今年第四季度开启临床试验。本次获批适应症为复发或难治性 CD19 阳性的 B 细胞血液肿瘤，包括 B 细胞急性淋巴细胞白血病（B-ALL）与 B 细胞非霍奇金淋巴瘤（B-NHL）的多种常见亚型。 莱芒生物由晶泰科技孵化，专注于开发新一代 AI 赋能的代谢增强型免疫疗法。其首个管线产品 META 10-19 已完成多项针对血液肿瘤、红斑狼疮等重大疾病的 IIT 研究（研究者发起临床研究），以低至常规 CAR-T 剂量千分之一的极低剂量，帮助数十位患者实现完全缓解（CR），有望以“极低剂量+免清淋”的创新策略，将单价百万的 CAR-T 疗法推进至平价时代。此次 META 10-19 注射液在美获批临床，标志着莱芒生物核心管线正式迈入全球化临床开发阶段，并再次展现了晶泰科技赋能孵化企业研发极具市场竞争力的创新疗法、并持续实现临床转化的高效率与高成功率，管线加速进入兑现期。 2025 年全球 CAR-T

BOSTON--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), the global leader in clinical-grade AI-powered pathology, today announced the launch of Ibex 4, its next-generation platform. Built on Ibex’s clinically validated algorithms1-10 and developed in close collaboration with the world’s leading pathology labs, Ibex 4 is designed to transform the diagnostic journey, delivering unprecedented value to pathologists, laboratories, and patients. As pathology departments worldwide face rising case volu

Platform Simplifies Sourcing as Peptide Demand Grows and Regulatory Frameworks Evolve TAMPA, Fla., March 18, 2026 /PRNewswire/ -- As peptide-based therapies expand across medical weight loss, hormone therapy, and performance-focused clinical programs, medical practices are demanding operational simplicity. BoomRx, the fastest-growing national pharmaceutical technology platform that simplifies prescription sourcing and fulfillment, meets that demand by making a range of peptide therapies availabl

Annual gathering highlights the future of precision medicine, peptides and proactive healthcare AUSTIN, Texas, March 18, 2026 /PRNewswire/ -- Medici, a precision medicine and preventative healthcare company, hosted its annual Medici Day on March 5-6 in Austin, bringing together nearly 300 leaders from healthcare, business, sports and investment to discuss longevity, peptides and proactive health. The multi-day event included the Medici Luncheon: The Art of Peptides, a celebrity golf tournament,

Patients identified through incidental findings are 6.2x more likely to be diagnosed with breast cancer compared to screening. More than half of incidental cancer diagnoses were among patients traditionally not eligible for routine screenings. BRENTWOOD, Tenn. and DENVER, March 18, 2026 /PRNewswire/ -- Lifepoint Health and Eon today released data from a large-scale breast cancer early detection program that challenges conventional assumptions about how breast cancer is detected and which patient